MORRIA



Trademark Coverage

No Class Specified

Pharmaceutical products and preparations for treating disease, namely, obstructive respiratory disease, asthma, inflammatory and anti-viral diseases, colitis, Crohn's disease, central nervous system insult, multiple sclerosis, contact dermatitis, psoriasis, cardiovascular disease, invasive cellular proliferative disorders, allergic rhinitis, cystic fibrosis, inflammatory disease of the skin, ophthalmologic diseases, hemolytic syndromes, sepsis, acute respiratory distress syndrome, tissue transplant rejection syndromes, autoimmune disease, viral infection, and hypersensitivity conjunctivitis; pharmaceuticals for use as a coating for cardiovascular stents and other stents; coating treatments, namely, pharmaceutical preparations used to coat devices for the prevention of inflammatory reactions as a result of invasive procedures; anti-oxidants supplements; pharmaceutical preparations, namely, anti-inflammatories and analgesics

Owner
Timeline
  • Oct 15
    2013
    Abandonment Notice Mailed No Use Statement Filed
  • Oct 14
    2013
    Abandonment No Use Statement Filed
  • Mar 29
    2013
    Notice Of Approval Of Extension Request E Mailed
  • Mar 28
    2013
    Extension 3 Granted
  • Mar 11
    2013
    Extension 3 Filed
  • Mar 26
    2013
    Case Assigned To Intent To Use Paralegal
  • Mar 11
    2013
    TEAS Extension Received
  • Sep 11
    2012
    Notice Of Approval Of Extension Request E Mailed
  • Sep 09
    2012
    Extension 2 Granted
  • Sep 06
    2012
    Extension 2 Filed
  • Sep 09
    2012
    Case Assigned To Intent To Use Paralegal
  • Sep 06
    2012
    TEAS Extension Received
  • Mar 15
    2012
    Notice Of Approval Of Extension Request E Mailed
  • Mar 13
    2012
    Extension 1 Granted
  • Mar 13
    2012
    Extension 1 Filed
  • Mar 13
    2012
    TEAS Extension Received
  • Mar 13
    2012
    TEAS Change Of Correspondence Received
  • Sep 13
    2011
    NOA E Mailed SOU Required From Applicant
  • Jul 19
    2011
    Official Gazette Publication Confirmation E Mailed
  • Jul 19
    2011
    Published For Opposition
  • Jun 14
    2011
    Law Office Publication Review Completed
  • Jun 13
    2011
    Approved For PUB Principal Register
  • Jun 13
    2011
    Examiner's Amendment Entered
  • Jun 13
    2011
    Notification Of Examiners Amendment E Mailed
  • Jun 13
    2011
    Examiners Amendment E Mailed
  • Jun 13
    2011
    Examiners Amendment Written
  • Jan 29
    2011
    Notification Of Final Refusal Emailed
  • Jan 29
    2011
    Final Refusal E Mailed
  • Jan 29
    2011
    Final Refusal Written
  • Jan 07
    2011
    TEAS/Email Correspondence Entered
  • Jan 07
    2011
    Correspondence Received In Law Office
  • Jan 07
    2011
    Assigned To LIE
  • Dec 09
    2010
    TEAS Response To Office Action Received
  • Jun 09
    2010
    Notification Of Non Final Action E Mailed
  • Jun 09
    2010
    Non Final Action E Mailed
  • Jun 09
    2010
    Non Final Action Written
  • Jun 09
    2010
    Assigned To Examiner
  • Mar 12
    2010
    New Application Office Supplied Data Entered In TRAM
  • Mar 11
    2010
    New Application Entered In TRAM